Development and Validation of Instruments to Measure Medication Adherence in Hypertensive Patients (MAHP): The Indonesian Case

Authors

Burhannudin Ichsan, Faculty of Medicine, Universitas Muhammadiyah SurakartaFollow
Erna Herawati, Faculty of Medicine, Universitas Muhammadiyah Surakarta
Sri W. Basuki, Faculty of Medicine, Universitas Muhammadiyah Surakarta
Ikhwansyah W. Pramudyatama, Faculty of Medicine, Universitas Muhammadiyah Surakarta
Umatul Khoiriyah, Department of Medical Education, Faculty of Medicine, Islamic University of Indonesia, Yogyakarta

Abstract

Background: Hypertension is a chronic disease that poses a significant public health issue globally. Medication adherence among hypertensive patients remains low, leading to various complications that adversely affect individuals, families, and the broader economy and society. To our knowledge, no specific instrument exists to measure medication adherence in hypertensive patients (MAHP) exclusively. This study aims to develop and validate an instrument to measure medication adherence and adherance-related behaviors among hypertensive patients.

Methods: The research consisted of two methods: (1) scale construction and (2) scale validation. The construction phase included: (1) defining the construct and its domains, (2) item development, (3) expert review using the Content Validity Index (CVI), and (4) assessing readability through response process testing. The validation phase included: (1) exploratory factor analysis (EFA), (2) confirmatory factor analysis (CFA), and (3) reliability testing using Cronbach’s alpha.

Results: EFA revealed four domains consistent with those identified through literature review and focus group discussions. However, item allocation led to renaming of certain domains. CFA confirmed that the resulting model had good fit.

Conclusion: The MAHP scale, consisting of four domains and eleven items related to medication adherence in hypertensive patients, has demonstrated sufficient evidence of its validity.

Keywords: Hypertension, Instrument, Medication adherence, Hypertensive patients, Indonesia

Recommended Citation

Ichsan B, Herawati E, Basuki S, Pramudyatama I, Khoiriyah U. Development and Validation of Instruments to Measure Medication Adherence in Hypertensive Patients (MAHP): The Indonesian Case. J Health Res. 2025; 39(6):-. DOI: https://doi.org/10.56808/2586-940X.1176

References

[1] World Health Organization [WHO]. Hypertension. [updated 2023 Mar 16; cited 2024 Nov 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.

[2] Marsya V, Mahmuda INN, Lestari N, Jatmiko SW. Correlations between age and hypertension on diabetic foot ulcer. Indonesi J Med 2023;8(2):179—85 [cited 2025 May 19]. Available from: https://www.theijmed.com/index.php/theijmed/article/view/622/pdf.

[3] Indonesia, Ministry of Health. Prevalence, impact and efforts to control hypertension and diabetes in Indonesia. [updated 2024 Nov 30; cited 2024 Nov 30]. Available from: https://p2ptm.kemkes.go.id/uploads/cEdQdm1WVXZuRXhad3FtVXduOW1WUT09/2024/09/factsheet%20PTM%2024aprl07.30.pdf.

[4] Indonesia, Ministry of Health. Prevalence, impact, and effort in controlling hypertension and diabetes in Indonesia. [cited 2025 Nov 14]. Available from: https://repository.badankebijakan.kemkes.go.id/id/eprint/5531/1/07%20factsheet%20PTM_English.pdf.

[5] Loots E, Goossens E, Vanwesemael T, Morrens M, Van Rompaey B, Dilles T. Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: A systematic review and meta-analysis. Int J Environ Res Publ Health 2021;18(19):10213. https://doi.org/10.3390/ijerph181910213.

[6] Karuniawati H, Rahmadi GI, Wikantyasning ER. Non- adherence factors to tuberculosis treatment in pulmonary tuberculosis patients in Surakarta Central General Hospital, Indonesia. Jurnal Farmasi Sains dan Praktis 2023;9(2): 193—201. https://doi.org/10.31603/pharmacy.v9i2.9109.

[7] Anderson LJ, Nuckols TK, Coles C, Le MM, Schnipper JL, Shane R, et al. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm 2020;77(2):138—47. https://doi.org/10.1093/ajhp/zxz284.

[8] Cholisoh Z, Karuniawati H, Azizah T, Zaenab Hekmah LN. Factors affecting non adherence to secondary stroke prevention therapy in ischemic stroke patients. Jurnal Manajemen dan Pelayanan Farmasi 2018;8(2):90—9. https://doi.org/10.22146/jmpf.34469.

[9] Andala S, Sofyan H, Hasballah K, Marthoenis. Knowledge and acceptance associated with medication adherence among hypertension individuals in Aceh province, Indonesia. Heliyon 2024;10(7):e29303. https://doi.org/10. 1016/j.heliyon.2024.e29303.

[10] Wahyuni AS, Mukhtar Z, Pakpahan DJR, Guhtama MA, Diansyah R, Situmorang NZ, et al. Adherence to consuming medication for hypertension patients at primary health care in Medan City. Open Access Maced J Med Sci 2019;7(20): 3483—7. https://doi.org/10.3889/oamjms.2019.683.

[11] Annisya DS, Ovikariani Murtisiwi L. Relationship between patient characteristics and the level of adherence to the use of hypertension drug in hypertensive patients at the Gajahan Health Center Surakarta. Indones J Med Sci 2024;11(2): 154—60. https://doi.org/10.70050/ijms.v11i2.495.

[12] Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence. Br J Clin Pharmacol 2020; 86(7):1281—8. https://doi.org/10.1111/bcp.14193.

[13] De Las Cuevas C, Pe~nate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. Int J Clin Health Psychol 2015;15(2):121—9. https://doi.org/10.1016/j.ijchp.2014.11.003.

[14] Alotaibi SA, Alrukban NA, Alanizy LN, Saleh A, Alsfouk BA. Development and validation of a new adherence scale for antiseizure medications [ASASM]. J Clin Med 2024;13(24):7844. https://doi.org/10.3390/jcm13247844.

[15] Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 2000;15(3):90—6. https://doi.org/10.1111/j.1751-7117.2000.tb00211.x.

[16] Lam WY, Fresco P. Medication adherence measures: An overview. BioMed Res Int 2015;2015:217047. https://doi.org/10.1155/2015/217047.

[17] Commodore-Mensah Y, Delva S, Ogungbe O, Smulcer LA, Rives S, Dennison Himmelfarb CR, et al. A systematic review of the hill-bone compliance to blood pressure therapy scale. Patient Prefer Adherence 2023;17:2401—20. https://doi.org/10.2147/PPA.S412198.

[18] Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS One 2017;12(11):e0187139. https://doi.org/10.1371/journal.pone.0187139.

[19] Culig J, Leppee M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol 2014;38(1):55—62. [20] Nassar RI, Basheti IA, Saini B. Exploring validated self-reported instruments to assess adherence to medications used: A review comparing existing instruments. Patient Prefer Adherence 2022;16. https://doi.org/10.2147/PPA.S352161.503-3.

[21] Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999;37(2):113—24. https://doi.org/10.1016/s0738-3991(98)00107-4.

[22] Pratama ANW, Aulia F, Christianty FM. Validity and reliability of the Indonesian version of the Self-Efficacy for Appropriate Medication use Scale (SEAMS-I). Pharm Educ 2022;22(2):45—9. https://doi.org/10.46542/pe.2022.222.4549.

[23] Schulz M, Day RO, Coleshill MJ, Briggs NE, Aung E. Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout. Clin Rheumatol 2024;43(9):2943—54. https://doi.org/10.1007/s10067-024-07050-y.

[24] Netemeyer RG, Bearden WO, Sharma S. Scaling procedures, issues and applications. London: Sage; 2003.

[25] Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med 2006;119(2). https://doi.org/10.1016/j.amjmed.2005.10.036.166.e7-16.

[26] Downing SM. Validity: on meaningful interpretation of assessment data. Med Educ 2003;37(9):830—7. https://doi.org/10.1046/j.1365-2923.2003.01594.x.

[27] Dinata RD, Muhlisin A. The relationship between the level of knowledge about hypertension and efforts to prevent hypertension complications in the elderly. Indonesian Journal of Global Health Research 2024;6(S6):319—26. https://doi.org/10.37287/ijghr.v6iS6.4722.

[28] World Health Organization [WHO]. Adherence to long- term therapies, evidence for action. [cited 2025 May 18]. Available from: https://iris.who.int/bitstream/handle/10665/42682/9241545992.pdf.

[29] Costello AB, Osborne J. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Practical Assess Res Eval 2005;10(7):1—9. https://doi.org/10.7275/jyj1-4868.

[30] Khoiriyah U, Roberts C, Jorm C, Van der Vleuten CP. Enhancing students' learning in problem based learning: validation of a self-assessment scale for active learning and critical thinking. BMC Med Educ 2015;15:140. https://doi.org/10.1186/s12909-015-0422-2.

[31] Sun J. Assessing goodness of fit in confirmatory factor analysis. Meas Eval Couns Dev 2005;37(4):240—56. https://doi.org/10.1080/07481756.2005.11909764.

[32] Roos JM, Bauldry S. Confirmatory factor analysis. London: Sage; 2022.